CNR validation of our first SARS-CoV-2 detection test by RT-qPCR
Laboratoire OBO, France – 17 June 2021
The CNR has validated the 1st RT-qPCR test that can detect SARS-CoV-2 launched under the OSANTYS brand, a trademark of Laboratoire OBO. The evaluation of the analytical performance for detecting SARS-CoV-2 in comparison with the CNR IPP reference technique has provided very encouraging results for the company’s first test.
The CNR, headed by Pr. B. Lina (Lyon), highlighted the qualities of our test : ‘The OSANTYS SARS-CoV-2 RT-qPCR test kit from Laboratoire OBO has a slightly higher sensitivity than the reference technique CNR IPP. The test is easy to use and the RT-qPCR takes 60 minutes.’